15706-88-4

Basic information

• Product Name: H-ARG-ASP-OH ACOH
• Synonyms: L-ARG-ASP;L-ARGINYL-L-ASPARTIC ACID;L-ARGINYL-L-ASPARTIC ACID ACETATE;ARG-ASP;H-ARG-ASP-OH;H-ARG-ASP-OH ACOH;arg-asp free base;L-arginyl-aspartic acid
• CAS NO: 15706-88-4
• Molecular Formula: C12H23N5O7
• Molecular Weight: 349.34
• Mol File: 15706-88-4.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• Storage Temp.: -15°C
• CAS DataBase Reference: H-ARG-ASP-OH ACOH(CAS DataBase Reference)
• NIST Chemistry Reference: H-ARG-ASP-OH ACOH(15706-88-4)
• EPA Substance Registry System: H-ARG-ASP-OH ACOH(15706-88-4)

Safety Data

• Hazardous Substances Data: 15706-88-4(Hazardous Substances Data)

Usage

Description

H-ARG-ASP-OH ACOH is a peptide compound consisting of the amino acids arginine (ARG) and aspartic acid (ASP) connected by an amide linkage, with a carboxylic acid derivative featuring a hydroxyl group and an acetyl group. This C16H28N4O7 molecule is crucial in research and biochemical studies, focusing on protein structure, function, pharmaceutical development, and drug delivery systems. Its unique properties and structure contribute to the understanding of biological processes and hold potential for therapeutic applications.

Uses

Used in Pharmaceutical Development:
H-ARG-ASP-OH ACOH is utilized as a building block in the design and synthesis of novel pharmaceuticals, targeting specific biological processes and offering potential therapeutic benefits.
Used in Drug Delivery Systems:
In drug delivery research, H-ARG-ASP-OH ACOH is employed as a component in the development of innovative systems, enhancing the efficiency and targeting of drug administration.
Used in Biochemical Studies:
H-ARG-ASP-OH ACOH is used as a research tool to investigate protein structure and function, providing insights into the molecular mechanisms underlying various biological processes.
Used in Research and Development:
H-ARG-ASP-OH ACOH is applied across different scientific fields as a versatile compound for the exploration of new methodologies and applications in both basic and applied research.

Upstream product

• 70543-59-8 N-(N^α-benzyloxycarbonyl-N^ω-nitro-L-arginyl)-L-aspartic acid 
• 122517-23-1 N-(N^α-benzyloxycarbonyl-N^ω-nitro-L-arginyl)-L-aspartic acid dibenzyl ester 
• 122315-62-2 N-(N^α,N^δ,N^ω-tris-benzyloxycarbonyl-L-arginyl)-L-aspartic acid dibenzyl ester 
• 14611-34-8 N^α,N^δ,N^ω-tris(benzyloxycarbonyl)-L-arginine 
• 2304-98-5 N₅-[imino(nitroamino)methyl]-N₂-[(phenylmethoxy)carbonyl]-L-ornithine 
• 70543-58-7 N-(N^α-benzyloxycarbonyl-N^ω-nitro-L-arginyl)-L-aspartic acid diethyl ester 
• 2149-70-4 N-nitro-L-arginine 
• 1119-34-2 L-arginine hydrochloride 
• 56-84-8 L-Aspartic acid 
• 74-79-3 L-arginine 

Downstream Products

• 56-84-8 L-Aspartic acid 
• 74-79-3 L-arginine 

Relevant articles and documents

Modelling of prebiotic synthesis and selection of peptides under isothermal conditions and thermal cycling mode

The model peptide synthesis from mixtures of amino acids was carried out under the thermal cycling and isothermal modes. The compositions of the obtained mixtures of products and the primary amino acid sequence of the synthesized peptides were determined by Fourier transform ion cyclotron resonance mass spectrometry and tandem mass spectrometry in combination with high-performance liquid chromatography with the application of de novo sequencing of the synthesized products. The processes of abiogenous synthesis of peptides were shown to occur under relatively mild temperature conditions and give a substantially less number of peptides as compared with the possible statistical set. The evolution of the system takes place in the process of the synthesis in solid phase with the disappearance of a series of the most unstable peptides. The selection process with the formation of complementary peptides takes place in peptide synthesis under the thermal cyclic mode.